Drug Patent Watch
DECEMBER 10, 2024
Quality Documentation and Manufacturing Expertise CDMOs are experienced in generating high-quality documentation required for regulatory submissions and have extensive expertise in drug development and manufacturing. link] UPM Pharmaceuticals. UPM Pharmaceuticals. 2021, May 2). link] Pharmaceutical Technology.
Express Pharma
APRIL 8, 2025
based Bionique Testing Laboratories (2021), and biologics CDMO Bionova Scientific (2022). These technologies are part of the larger effort to support pharmaceutical manufacturers with enhanced process efficiency and product safety.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
JANUARY 17, 2025
We have committed to reduce our scope 1 and 2 GHG emissions by 42 per cent (absolute) by the end of 2030 (from a 2021 basis). To achieve this goal, the company is focusing on transitioning to renewable electricity and carbon-free heat, reducing energy consumption, and redesigning manufacturing processes to reduce energy consumption and waste.
Putting Patients First Blog
MAY 6, 2025
4 ,5 Millions of Americans rely on medicines that are manufactured outside the United States, particularly from close and longstanding allies such as Ireland, Switzerland, and the United Kingdomcountries whose regulatory frameworks for pharmaceutical manufacturing mirror the high standards enforced domestically.
Pharmaceutical Technology
JUNE 19, 2025
billion from 2021 to 2025 year-to-date. Large pharmaceutical companies such as AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications, accounting for 63% of licensing deals between 2021 and 2025 year-to-date. ASOs accounted for more than half ($3.54
STAT
NOVEMBER 13, 2024
In the wake of the Covid-19 pandemic, the Food and Drug Administration continues to struggle with a lack of investigators needed to inspect domestic and foreign pharmaceutical manufacturing plants and has not yet developed a plan to keep needed staff, a U.S. government watchdog found.
European Pharmaceutical Review
JULY 15, 2022
The pharmaceutical sector is not typically seen as a highly polluting, ‘heavy industry’ but it is far from green. In its 2021 report Delivering a ‘Net Zero’ National Health Service , the UK’s NHS attributes as much as a quarter of its carbon footprint to medicines. About the author.
Expert insights. Personalized for you.
94 
Let's personalize your content